PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.

Source:http://linkedlifedata.com/resource/pubmed/id/9191511

Download in:

View as

General Info

PMID
9191511